about
Cloning and mapping of members of the MYM familyThe application of single nucleotide polymorphism microarrays in cancer researchIdentification of seven new prostate cancer susceptibility loci through a genome-wide association studySeven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyAlternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomasIdentification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expressionTranscription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?ICAAR, a novel member of a new family of transmembrane, tyrosine phosphatase-like proteins.Gonorrhea and Prostate Cancer Incidence: An Updated Meta-Analysis of 21 Epidemiologic Studies.Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population.MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity.Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells.NKAIN2 functions as a novel tumor suppressor in prostate cancer.The complexity of prostate cancer: genomic alterations and heterogeneity.Use of SNPs in cancer predisposition analysis, diagnosis and prognosis: tools and prospects.Molecular characterisation of the t(1;15)(p22;q22) translocation in the prostate cancer cell line LNCaP.SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns.Evaluation of 24-color multifluor-fluorescence in-situ hybridization (M-FISH) karyotyping by comparison with reverse chromosome painting of the human breast cancer cell line T-47D.Protein S-palmitoylation and cancer.Postchemotherapy changes in testicular germ cell tumours: biology and morphology.TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer.DNA replication-dependent induction of gene proximity by androgen.GLI2 induces genomic instability in human keratinocytes by inhibiting apoptosisIdentification of ZDHHC14 as a novel human tumour suppressor gene.Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.Genomic copy number and expression patterns in testicular germ cell tumours.Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression.Identification of a recurrent t(4;6) chromosomal translocation in prostate cancer.Overexpression of genes on 16q associated with cisplatin resistance of testicular germ cell tumor cell lines.Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior.Establishment and characterization of a SV40T-transformed human bronchial epithelial cell line.Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing.Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis.
P50
Q22010379-AB1DDC77-EC40-40C3-8E91-F62F9F5D41C1Q24653582-C1470E90-3226-4467-8181-AEDF450E60E5Q29417022-D1A6DB40-3F58-4B57-A49E-D127070E7063Q29417074-D3C9D560-12E0-4F99-A44C-69370E3731B9Q33846990-ABBB2820-00FA-4488-A50F-C97B4B203362Q33894922-7C8B4B87-1271-41E8-BF76-542D7B18EA46Q33930344-4C096C64-DE51-4630-A89C-023A9793073EQ34247934-CD7F6DA5-FFC0-423F-8A3A-C06D23CAFCF8Q34410356-EB9C0C7B-EFA6-4AB4-8DD6-E4DA917DF59FQ35679037-1DF991B1-4934-45F4-988F-41DA7EFB890BQ35784738-EAEB32E5-A993-435A-86D0-A7E908F8C65DQ35815958-4BFFB1FE-3C1C-4978-A47B-519FDB032FC2Q36477652-08EFDB35-A9C0-46EC-B4B7-CB6812E6DB9AQ36609819-81DB96EB-F879-4130-9F5B-D1B10974F52AQ37225298-99069BBE-C7A5-43D9-A689-682E5C1EC782Q37565167-2AE3E4E8-6F1E-4425-93E7-42E7D67070F5Q37663786-F10F7AE8-9BEA-44F0-B2F1-4286AF36A758Q37665477-5B9167C3-55B2-4D02-87D1-914A89F6CA8DQ38058243-6082A21E-7F92-4C12-AF2C-6984D1A96952Q38089070-AD92DC9C-EEFF-47F2-B7EF-31CD8B1B2206Q38319022-48394C06-38CD-44E5-9994-8F3013FD5B79Q38382935-E433081D-70B3-4C51-A6EF-928DEC5D78D7Q38497055-921C2FA1-5A51-4728-8BFE-82EF76DFFEC2Q38538067-56238B82-FCF3-4331-8BFF-5367F19AECDFQ38783396-9A84ED70-C134-44BE-9A4C-EA06CF8C4EE3Q38805821-11E9B3EF-CF32-4E8B-8CB4-86F0B2CFDA9FQ38950671-3B693DF6-7CB1-4D22-8684-AB5ADE897CE7Q39028802-E81C5CD6-004D-4B5D-A9BE-255F3D6F0379Q39035797-551C2C6D-0559-403F-91FB-EF3B7824ED19Q39052828-9C8F9459-09DB-4362-9DB6-D10B9F265179Q39643971-276CBBB7-587D-45C6-9AF6-EB43013A2CDDQ39876991-681E37AC-CA3C-401E-BF04-EE6D207CDB95Q40039629-01BDE408-B95B-4D04-86CF-D6BB6317A6A7Q40079123-DE3C5061-FD1B-486E-9DA9-35ABBBF9F68DQ40145178-676D01DB-7CBE-4636-B55A-E4B9C25E1E4DQ40447867-22B80700-2CA9-41E8-B946-411E61B6D8FEQ40631853-0EB2E217-7200-4C37-B5AA-C862CCEDB37AQ41061116-329D0E18-C210-4126-AD9D-51AA62F8D456Q41925248-DF9C878C-BD72-4DEB-A05D-E1D09C2D53F7Q42089044-3E171729-C750-42F8-B876-01FA964B8301
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yong-Jie Lu
@ast
Yong-Jie Lu
@en
Yong-Jie Lu
@es
Yong-Jie Lu
@nl
Yong-Jie Lu
@sl
type
label
Yong-Jie Lu
@ast
Yong-Jie Lu
@en
Yong-Jie Lu
@es
Yong-Jie Lu
@nl
Yong-Jie Lu
@sl
prefLabel
Yong-Jie Lu
@ast
Yong-Jie Lu
@en
Yong-Jie Lu
@es
Yong-Jie Lu
@nl
Yong-Jie Lu
@sl
P106
P1153
57189528651
P31
P496
0000-0001-6174-6621